Crossmark

Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03

Crossref DOI link: https://doi.org/10.1007/s00259-024-06634-9

Published Online: 2024-02-20

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wen, Xuejun

Wang, Rongxi

Xu, Pengfei

Shi, Mengqi

Shang, Qingyao

Zeng, Xueyuan

Zeng, Xinying

Liu, Jia

Wang, Xin

Zhu, Zhaohui

Guo, Zhide

Chen, Xiaoyuan

Zhang, Jingjing https://orcid.org/0000-0002-6948-1813
Funding

Funding for this research was provided by:

National Medical Research Council, Singapore (MOH-001334-00)
License Information

Text and Data Mining valid from 2024-02-20

Version of Record valid from 2024-02-20
More Information

Article History

Received: 30 October 2023

Accepted: 4 February 2024

First Online: 20 February 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below